No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Established in 1967 and based in Indore, India, Alpa Laboratories Limited specializes in the development and marketing of a diverse portfolio of finished pharmaceutical dosage forms. Their extensive product range includes ethical, generic, and over-the-counter (OTC) medications, presented as injections, tablets, capsules, eye/ear drops, ointments, creams, and gels, catering to both human and veterinary needs. The company's therapeutic categories are broad, encompassing anti-infectives (such as antibacterials, antibiotics, antifungals, antiprotozoals, and antivirals), analgesics, anti-inflammatory drugs, cough and cold remedies, cardiovascular medications, anti-diabetics, nutritional supplements, psychotropic treatments, and dermatological, ophthalmic, and otic preparations. Alpa Laboratories distributes its products throughout India through a network of distributors, retail chemists, pharmacies, and hospitals. Additionally, the company maintains an international presence, exporting to regions including South and Central America, Africa, Asia, Russia, Ukraine, and Kazakhstan.
www.alpalabs.inNo one on the platform currently holds ALPA.BO.
No tracked institution reports a position in ALPA.BO as of their last filing.
No one on the platform has traded ALPA.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ALPA.BOAlpa Laboratories Limited | $60.00 | -0.94% | $1.3B | — |
| AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited | $96.50 | -2.35% | $2.7B | — |
| AASHKA.BOAashka Hospitals Limited | $83.28 | -2.00% | $1.9B | — |
| ACHYUT.BOAchyut Healthcare Ltd. | $6.85 | +0.44% | $1.7B | — |
| BALPHARMA.BOBal Pharma Limited | $100.95 | -5.97% | $1.6B | — |
| BALPHARMA.NSBal Pharma Limited | $101.99 | -5.07% | $1.6B | — |
| CORALAB.BOCoral Laboratories Limited | $567.20 | +0.29% | $2.0B | — |
Source: Financial Modeling Prep · peers by sector/industry